These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33887763)

  • 1. Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.
    Taha B; Li T; Boley D; Chen CC; Sun J
    Neurosurgery; 2021 Jul; 89(2):323-328. PubMed ID: 33887763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI Features May Predict Molecular Features of Glioblastoma in
    Park CJ; Han K; Kim H; Ahn SS; Choi D; Park YW; Chang JH; Kim SH; Cha S; Lee SK
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):448-456. PubMed ID: 33509914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study.
    Price SJ; Allinson K; Liu H; Boonzaier NR; Yan JL; Lupson VC; Larkin TJ
    Radiology; 2017 Apr; 283(1):215-221. PubMed ID: 27849434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.
    Xing Z; Zhang H; She D; Lin Y; Zhou X; Zeng Z; Cao D
    Acta Radiol; 2019 Dec; 60(12):1663-1672. PubMed ID: 31084193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.
    Shimizu T; Matsushima S; Fukasawa N; Akasaki Y; Mori R; Ojiri H
    J Clin Neurosci; 2020 Jun; 76():140-144. PubMed ID: 32291242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
    Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
    Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
    Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of Radiomics in Glioblastoma.
    Taha B; Boley D; Sun J; Chen CC
    Neurosurgery; 2021 Jul; 89(2):177-184. PubMed ID: 33913492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas.
    Takase H; Togao O; Kikuchi K; Hata N; Hatae R; Chikui T; Tokumori K; Kami Y; Kuga D; Sangatsuda Y; Mizoguchi M; Hiwatashi A; Ishigami K
    Br J Radiol; 2022 May; 95(1133):20210392. PubMed ID: 35138915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma.
    Lasocki A; Tsui A; Gaillard F; Tacey M; Drummond K; Stuckey S
    J Clin Neurosci; 2017 May; 39():170-175. PubMed ID: 28214089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.
    Patel SH; Batchala PP; Muttikkal TJE; Ferrante SS; Patrie JT; Fadul CE; Schiff D; Lopes MB; Jain R
    J Neurooncol; 2021 May; 152(3):523-531. PubMed ID: 33661425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.
    Su X; Sun H; Chen N; Roberts N; Yang X; Wang W; Li J; Huang X; Gong Q; Yue Q
    Clin Radiol; 2020 Dec; 75(12):963.e7-963.e15. PubMed ID: 32921406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type.
    Park JE; Eun D; Kim HS; Lee DH; Jang RW; Kim N
    Sci Rep; 2021 May; 11(1):9912. PubMed ID: 33972663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.
    Choi YS; Bae S; Chang JH; Kang SG; Kim SH; Kim J; Rim TH; Choi SH; Jain R; Lee SK
    Neuro Oncol; 2021 Feb; 23(2):304-313. PubMed ID: 32706862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided diagnosis of isocitrate dehydrogenase genotypes in glioblastomas from radiomic patterns.
    Lo CM; Weng RC; Cheng SJ; Wang HJ; Hsieh KL
    Medicine (Baltimore); 2020 Feb; 99(8):e19123. PubMed ID: 32080088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.
    Lee MH; Kim J; Kim ST; Shin HM; You HJ; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
    World Neurosurg; 2019 May; 125():e688-e696. PubMed ID: 30735871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma.
    Li ZC; Bai H; Sun Q; Zhao Y; Lv Y; Zhou J; Liang C; Chen Y; Liang D; Zheng H
    Cancer Med; 2018 Dec; 7(12):5999-6009. PubMed ID: 30426720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma.
    Park JE; Kim HS; Park SY; Nam SJ; Chun SM; Jo Y; Kim JH
    Radiology; 2020 Feb; 294(2):388-397. PubMed ID: 31845844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor imaging-based machine learning for IDH wild-type glioblastoma stratification to reveal the biological underpinning of radiomic features.
    Wang Z; Guan F; Duan W; Guo Y; Pei D; Qiu Y; Wang M; Xing A; Liu Z; Yu B; Zheng H; Liu X; Yan D; Ji Y; Cheng J; Yan J; Zhang Z
    CNS Neurosci Ther; 2023 Nov; 29(11):3339-3350. PubMed ID: 37222229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased
    Koyasu S; Shimizu Y; Morinibu A; Saga T; Nakamoto Y; Togashi K; Harada H
    J Neurooncol; 2019 Dec; 145(3):441-447. PubMed ID: 31667733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.